SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-22-000135
Filing Date
2022-11-08
Accepted
2022-11-08 16:03:23
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20220930.htm   iXBRL 10-Q 1799126
2 EX-10.1 exhibit101-aremployeematte.htm EX-10.1 253580
3 EX-31.1 lgnd_93022exhibit311.htm EX-31.1 15151
4 EX-31.2 lgnd_93022exhibit312.htm EX-31.2 15360
5 EX-32.1 lgnd_93022exhibit321.htm EX-32.1 11280
11 lgnd-20220930_g1.jpg GRAPHIC 51754
  Complete submission text file 0000886163-22-000135.txt   8961732

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20220930.xsd EX-101.SCH 48275
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20220930_cal.xml EX-101.CAL 93984
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20220930_def.xml EX-101.DEF 261955
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20220930_lab.xml EX-101.LAB 666845
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20220930_pre.xml EX-101.PRE 424264
60 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20220930_htm.xml XML 1695370
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 221368793
SIC: 2834 Pharmaceutical Preparations